Page last updated: 2024-11-12
imidazoleacetic acid ribotide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
imidazoleacetic acid ribotide: metabolite of imidazole acetic acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 16019958 |
| CHEBI ID | 16805 |
| MeSH ID | M0249565 |
Synonyms (15)
| Synonym |
|---|
| [1-(5-phosphoribosyl)imidazol-4-yl]acetic acid |
| CHEBI:16805 , |
| [1-(5-phosphoribofuranosyl)imidazol-4-yl]acetic acid |
| imidazoleacetic acid ribotide |
| 2-[1-[(3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazol-4-yl]acetic acid |
| 2-{1-[(3r,4s,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1h-imidazol-4-yl}acetic acid |
| 1-ribosylimidazole-4-acetic acid 5'-phosphate |
| 1-b-d-ribofuranosyl-imidazole-4-acetic acid 5'-phosphate |
| imidazole-4-acetic acid ribotide |
| 1-b-d-ribofuranosyl-imidazole-4-acetic acid 5'-(dihydrogen phosphate) |
| 1-(5-o-phosphono-b-d-ribofuranosyl)-1h-imidazole-4-acetic acid |
| 1-(5-o-phosphono-beta-delta-ribofuranosyl)-1h-imidazole-4-acetic acid |
| 1-beta-delta-ribofuranosyl-imidazole-4-acetic acid 5'-(dihydrogen phosphate) |
| 1-beta-delta-ribofuranosyl-imidazole-4-acetic acid 5'-phosphate |
| Q27102082 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (4)
| Class | Description |
|---|---|
| N-glycosyl compound | A glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a nitrogen atom, thus creating a C-N bond. |
| ribose monophosphate | |
| imidazoles | A five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton. |
| monocarboxylic acid | An oxoacid containing a single carboxy group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.60) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||